News

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
TUESDAY, June 24, 2025 (HealthDay News) — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 ...
The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.
Related Beal, the Boston office of Related Cos., has topped out construction of Leiden Center II at Innovation Square, a 345,000-square-foot life sciences project in Boston. The 1.8-acre site is ...
WASHINGTON, DC — A woman in her late 80s with mild dementia ... Biopsies on two areas of the scalp vertex within 1 cm of each other and one on the neck revealed an SCC in situ on the scalp with an ...
When faced with the myriad diseases and equally numerous targets for potential drugs the company could pursue, Kewalramani ...
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 10 years ago, it would be worth $345.57 today based on a price of $445.20 for VRTX at the time of writing.
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...